Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Curanex Pharmaceuticals, Common Stock

CURX

NAQ

$8.43

-$0.17

(-1.98%)

Sector: Healthcare

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$238.51M

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

1.08M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

About Curanex Pharmaceuticals, Common Stock

Curanex Pharmaceuticals Inc is a developmental stage pharmaceutical company. The Company is engaged in discovering, developing, and commercializing botanical drugs to treat patients suffering from inflammatory diseases and to develop therapies that offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections. Its lead candidate, Phyto-N, is a botanical extract from a single plant with anti-inflammatory properties that act via multiple targets and mechanisms. Its drug development pipelines encompass six various therapeutic areas: ulcerative colitis, atopic dermatitis, COVID-19, diabetes, NAFLD, and gout. Phyto-N is being developed as an orally administered alternative for patients with moderate to severe ulcerative colitis, aiming to address limitations of current treatments. The Company's two botanical drugs include Veregen (sinecatechins) and Fulyzaq/Mytesi (crofelemer). more

Sector: Healthcare

Returns

Data is not properly formatted.

Time Frame	CURX		S&P500
1-Week Return	-%	%	1.33%%
1-Month Return	-%	%	2.18%%

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	CURX
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	CURX
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Curanex Pharmaceuticals share price today?

Curanex Pharmaceuticals (CURX) share price today is $8.43

Can Indians buy Curanex Pharmaceuticals shares?

Yes, Indians can buy shares of Curanex Pharmaceuticals (CURX) on Vested. To buy Curanex Pharmaceuticals from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CURX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Curanex Pharmaceuticals be purchased?

Yes, you can purchase fractional shares of Curanex Pharmaceuticals (CURX) via the Vested app. You can start investing in Curanex Pharmaceuticals (CURX) with a minimum investment of $1.

How to invest in Curanex Pharmaceuticals shares from India?

You can invest in shares of Curanex Pharmaceuticals (CURX) via Vested in three simple steps:

Click on Sign Up or Invest in CURX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Curanex Pharmaceuticals shares

What is Curanex Pharmaceuticals price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Curanex Pharmaceuticals (CURX) is 0.00

What is the Market Cap of Curanex Pharmaceuticals?

The market capitalization of Curanex Pharmaceuticals (CURX) is $238.51M

What is Curanex Pharmaceuticals’s stock symbol?

The stock symbol (or ticker) of Curanex Pharmaceuticals is CURX